A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age (cid:1) 70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer
暂无分享,去创建一个
M. Socinski | J. Beaumont | A. Peterman | T. Hensing | T. Stinchcombe | Carrie Lee | G. Schwartz | K. Bakri | H. Niell | M. Taylor | D. Bradford | H. Harper | D. Moore | S. Pal | E. McElroy | Jeffrey M. Crane